IP Library Granted Patent US 9,839,517
Granted Patent B2
US 9,839,517 · App. 14/865,436 · Granted Dec 12, 2017

Implantable device for treating mitral valve regurgitation

Inventors: Marcos Centola (São Paulo, BR); Emilia Kawa (Hechingen, DE)
Assignee: NVT AG
A61F2/2445A61F2/2418A61F2230/0069A61F2230/0071
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,839,517
App. No.
14/865,436
Granted
Dec 12, 2017
Kind
B2
Abstract

An implantable device for treating mitral valve regurgitation, the device being configured to expand from a compressed state into an expanded state. The device comprises a stent element consisting of (i) an atrial anchoring stent-portion, and (ii) a valve-carrying stent-portion being fixedly connected with one another, and a valve-element. The atrial anchoring stent-portion has a balloon-like shape and the valve-carrying stent-portion has a cylindrical shape, such, that the valve-carrying stent-portion is positioned intra-annular without contacting the annulus of a native mitral valve.

Claims (21)

1. Implantable device for treating mitral valve regurgitation, the device being configured to expand from a compressed state into an expanded state, and comprising:

a stent element comprising

an atrial anchoring stent-portion, and

a valve-carrying stent-portion,

the atrial anchoring stent-portion being fixedly connected with the valve-carrying stent-portion,

wherein the atrial anchoring portion, in the expanded state of the device, has a balloon-like shape and is so dimensioned as to have a diameter which is larger than a diameter of an annulus of a native mitral valve present between an atrium and a ventricle of a heart to be treated, and is so dimensioned and configured to anchor the device via radial force in an atrium of a heart to be treated when the device is in the expanded state,

wherein the valve-carrying stent-portion, in the expanded state of the device, has a substantially cylindrical shape with a diameter (d 3 ) which, in the expanded state, is so dimensioned as to be smaller than a diameter of an annulus of a native mitral valve of a heart to be treated, such that there is no contact between the annulus of the native mitral valve and the valve-carrying stent-portion; and

a valve element comprising a skirt-portion and a valve-portion, the skirt-portion being externally mounted to the valve-carrying stent-portion, and the valve-portion being internally mounted to the valve-carrying stent-portion.

2. The device of claim 1 , wherein, when implanted, the valve-element is so dimensioned and configured such that the native mitral valve's function is supported without replacing or impairing the native mitral valve's function.

3. The device of claim 1 , wherein the atrial anchoring stent-portion and the valve-carrying stent-portion are integrally formed.

4. The device of claim 1 , wherein the atrial anchoring stent-portion is configured to be anchorable in an atrium of a heart.

5. The device of claim 1 , wherein the skirt-portion and the valve-portion of the valve element are made of a same material.

6. The device of claim 5 , wherein the skirt-portion and the valve-portion of the valve element are made of pericardium.

7. The device of claim 1 , wherein the valve element is a bi- or tri-leaflet valve.

8. The device of claim 1 , wherein the stent-element is made of a shape-memory material.

9. The device of claim 8 , wherein the stent-element is a laser-cut stent-element and/or composed of wires.

10. The device of claim 8 , wherein the atrial anchoring stent-portion and/or the valve-carrying stent-portion is made from braided or otherwise intersected wires.

11. The device of claim 8 , wherein the atrial anchoring stent-portion and/or the valve-carrying stent-portion is made from wire-loops.

12. The device of claim 8 , wherein the stent-element is made of ninitol.

13. The device of claim 1 , wherein the substantially cylindrical shape of the valve-carrying stent-portion, in the expanded state of the device, has a substantially continuous diameter (d 3 ) along its cylindrical length (l).

14. Method for treating mitral valve regurgitation, the method comprising the step of deploying the device as claimed in claim 1 in a heart of a patient in need of being treated.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2020
From: NVT AG
To: MEDIRA AG
Reel/Frame 053013/0972 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2016
From: CENTOLA, MARCOS; KAWA, EMILIA
To: NVT AG
Reel/Frame 037941/0156 →
Priority Claims (1)
EP 14186503 · Sep 26, 2014 · regional
Continuity (1)
Related Publication 20160089238A1 · Mar 31, 2016